State Street Corp Reduces Stock Holdings in Amedisys, Inc. (NASDAQ:AMED)

State Street Corp reduced its holdings in Amedisys, Inc. (NASDAQ:AMED) by 1.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 950,560 shares of the health services provider’s stock after selling 16,936 shares during the period. State Street Corp owned about 2.90% of Amedisys worth $91,739,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Alpine Associates Management Inc. boosted its holdings in Amedisys by 0.9% during the second quarter. Alpine Associates Management Inc. now owns 1,280,897 shares of the health services provider’s stock worth $117,586,000 after buying an additional 11,000 shares in the last quarter. Westchester Capital Management LLC boosted its holdings in Amedisys by 9.5% during the third quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider’s stock worth $107,976,000 after buying an additional 97,476 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Amedisys by 4.0% during the second quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock worth $47,202,000 after buying an additional 19,660 shares in the last quarter. Calamos Advisors LLC boosted its holdings in Amedisys by 11.6% during the second quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider’s stock worth $36,476,000 after buying an additional 41,220 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Amedisys by 2.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider’s stock worth $33,400,000 after buying an additional 9,004 shares in the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Stock Performance

Shares of NASDAQ AMED opened at $85.82 on Tuesday. The company’s fifty day moving average price is $92.46 and its 200 day moving average price is $94.86. Amedisys, Inc. has a 1 year low of $84.06 and a 1 year high of $98.95. The company has a market capitalization of $2.81 billion, a PE ratio of 34.06, a price-to-earnings-growth ratio of 1.84 and a beta of 0.73. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The firm had revenue of $587.67 million for the quarter, compared to analysts’ expectations of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business’s quarterly revenue was up 5.7% on a year-over-year basis. During the same period last year, the company posted $0.98 earnings per share. On average, research analysts predict that Amedisys, Inc. will post 4.45 earnings per share for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.